Although there is a growing body of literature describing changes in the immunologic profiles of patients receiving treatment for cervical cancer, most are limited to broad characterizations of lymphocyte fluctuations and lack detail about behavior of specific subsets of CD4 and CD8 cells. Here, CD4 is linked to cervical carcinoma.